Denali Therapeutics (DNLI) Prepaid Assets (2017 - 2026)

Denali Therapeutics (DNLI) has 10 years of Prepaid Assets data on file, last reported at $35.1 million in Q1 2026.

• Prepaid Assets for Q1 2026 came in at $35.1 million, down 42.24% year-over-year; the trailing twelve-month figure through Mar 2026 was $35.1 million (down 42.24% YoY), and the FY2025 annual result was $32.8 million, up 2.1% from the prior year.
• Prepaid Assets advanced to $35.1 million in Q1 2026 per DNLI's latest filing, from $32.8 million in the prior quarter.
• Over five years, Prepaid Assets peaked at $60.7 million in Q1 2025 and troughed at $29.6 million in Q4 2023.
• A 5-year average of $35.9 million and a median of $33.6 million in 2023 frame the typical range for Prepaid Assets.
• The sharpest annual moves came in 2022 and 2026: Prepaid Assets soared 184.33% in 2022, then tumbled 42.24% in 2026.
• A 5-year view of Prepaid Assets shows it stood at $36.1 million in 2022, then decreased by 17.94% to $29.6 million in 2023, then gained by 8.37% to $32.1 million in 2024, then grew by 2.1% to $32.8 million in 2025, then rose by 6.98% to $35.1 million in 2026.
• Business Quant data shows DNLI's Prepaid Assets at $35.1 million in Q1 2026, $32.8 million in Q4 2025, and $34.4 million in Q3 2025.